| Financial Year |
March 31 2023 |
| Monetary Funds |
1,504,411,692.77 |
| Held-for-trading Financial Assets |
328,164,477.42 |
| Notes Receivable |
3,987,654.46 |
| Accounts Receivable |
178,566,791.27 |
| Advances to Suppliers |
47,133,186.19 |
| Other Receivables |
12,921,183.34 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
544,789,204.09 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
7,144,000.00 |
| Other Current Assets |
6,447,892.86 |
| Total Current Assets |
2,633,566,082.40 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
13,945,743.51 |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
384,481,329.94 |
| Under-construction Projects |
183,517,530.49 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
167,091,238.67 |
| R&D expenses |
-- |
| Goodwill |
178,518,412.13 |
| Long-Term Deferred and Prepaid Expenses |
12,968,506.50 |
| Deferred Income Tax Assets |
37,259,737.87 |
| Other Non-Current Assets |
36,632,902.59 |
| Sub-Total of Non-Current Assets |
1,058,892,856.05 |
| Total Assets |
3,692,458,938.45 |
| Short-Term Loans |
230,509,110.55 |
| Trading Financial liabilities |
763,342.30 |
| Notes Payable |
1,175,279.30 |
| Accounts Payable |
188,067,865.96 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
71,181,248.69 |
| Taxes Payable |
39,919,643.56 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
62,652,112.15 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
10,950,565.33 |
| Other Current Liabilities |
7,483,552.89 |
| Sub-Total of Current Liabilities |
709,739,029.05 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
997,025.44 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
53,048,275.40 |
| Total Liabilities |
762,787,304.45 |
| Paid-In Capital(Or Share Stock) |
430,652,785.00 |
| Capital Surplus |
1,087,038,217.20 |
| Surplus Reserve |
153,612,731.38 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
1,240,417,921.18 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,929,671,634.00 |
| Owner's Equity（Stockholder's Equity） |
2,929,671,634.00 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,692,458,938.45 |
